Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone Acetonide as Adjunct to Ranibizumab in Wet ARMD
NCT01249937Phase 2Unknown
- Sponsor
- University Health Network
- Start
- Jan 2011
- Primary completion
- Jul 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of triamcinolone acetonide in exudative macular degeneration, sponsored by University Health Network. Status: unknown.
02
Drugs
triamcinolone acetonide
03
Conditions
exudative macular degeneration
Beyond the preview
Go deeper on NCT01249937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01249937.